Millennium Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.11M Sell
24,300
-5,400
-18% -$1.77M ﹤0.01% 2550
2025
Q4
$10.4M Buy
29,700
+11,300
+61% +$3.82M ﹤0.01% 2222
2025
Q3
$5.95M Buy
18,400
+2,900
+19% +$902K ﹤0.01% 2963
2025
Q2
$6.03M Sell
15,500
-11,300
-42% -$4.55M ﹤0.01% 2795
2025
Q1
$11.7M Sell
26,800
-7,200
-21% -$2.89M 0.01% 2029
2024
Q4
$12.5M Sell
34,000
-120,700
-78% -$50.5M 0.01% 1968
2024
Q3
$80.4M Buy
154,700
+300
+0.2% +$160K 0.04% 548
2024
Q2
$83.7M Sell
154,400
-8,200
-5% -$4.33M 0.04% 503
2024
Q1
$84.3M Buy
162,600
+8,800
+6% +$4.38M 0.04% 545
2023
Q4
$72.5M Sell
153,800
-72,800
-32% -$33.7M 0.03% 570
2023
Q3
$98.7M Buy
226,600
+110,600
+95% +$50.2M 0.05% 380
2023
Q2
$51.5M Buy
116,000
+30,200
+35% +$13.9M 0.03% 718
2023
Q1
$39.5M Sell
85,800
-197,100
-70% -$93.8M 0.02% 848
2022
Q4
$145M Buy
282,900
+29,300
+12% +$14.9M 0.08% 241
2022
Q3
$115M Buy
253,600
+90,100
+55% +$43.1M 0.07% 272
2022
Q2
$78.9M Buy
163,500
+18,200
+13% +$9M 0.05% 402
2022
Q1
$71.4M Buy
145,300
+8,400
+6% +$3.84M 0.04% 493
2021
Q4
$63.5M Buy
136,900
+97,900
+251% +$41.2M 0.03% 586
2021
Q3
$14.5M Buy
39,000
+14,200
+57% +$5.4M 0.01% 1616
2021
Q2
$9.47M Buy
24,800
+20,300
+451% +$7.76M 0.01% 1981
2021
Q1
$1.61M Buy
4,500
+2,500
+125% +$804K ﹤0.01% 3736
2020
Q4
$642K Buy
+2,000
New +$614K ﹤0.01% 4020
2020
Q3
Sell
-27,200
Closed -$7.15M 4537
2020
Q2
$7.15M Buy
27,200
+19,200
+240% +$5.12M 0.01% 1467
2020
Q1
$1.82M Buy
8,000
+6,400
+400% +$1.74M ﹤0.01% 2092
2019
Q4
$483K Buy
+1,600
New +$440K ﹤0.01% 3402
2019
Q3
Sell
-51,600
Closed -$14.6M 4258
2019
Q2
$14.6M Buy
+51,600
New +$14.1M 0.02% 988
2014
Q4
Sell
-1,800
Closed -$215K 3996
2014
Q3
$215K Buy
+1,800
New +$206K ﹤0.01% 3367

Other funds holding ELV

Millennium Management's ELV Position: Q1 2026 in Review

Millennium Management increased its Elevance Health (ELV) stake by 103% in Q1 2026, buying an estimated $153M and bringing the position to 919,171 shares worth $269M. The position accounts for 0.11% of the portfolio, ranked #154.

Millennium Management first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $431M in Q3 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Millennium Management held 919,171 shares of Elevance Health worth $269M as of Q1 2026.
  • Millennium Management bought 466,051 Elevance Health shares in Q1 2026, an estimated $153M.
  • Elevance Health made up 0.11% of Millennium Management's portfolio in Q1 2026, its #154 holding.
  • Millennium Management first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
  • Millennium Management's Elevance Health position peaked at $431M in Q3 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.